These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Can circulating interleukin-18 differentiate between sarcoidosis and idiopathic pulmonary fibrosis?
    Author: Liu DH, Cui W, Chen Q, Huang CM.
    Journal: Scand J Clin Lab Invest; 2011 Nov; 71(7):593-7. PubMed ID: 21834618.
    Abstract:
    OBJECTIVE: The aim of the present study was to investigate serum and bronchoalveolar lavage fluid (BALF) interleukin-18 (IL-18) levels in sarcoidosis and idiopathic pulmonary fibrosis (IPF) and to assess the clinical usefulness of IL-18 in these diseases. METHODS: Serum and BALF levels of IL-18 were measured in 15 patients with sarcoidosis, 10 patients with IPF and 24 control subjects (8 with lung tumor, 6 with pulmonary tuberculosis and 10 healthy controls). Lymphocyte fractions (T, B and natural killer (NK) cells) in blood and BALF were analysed by flow cytometer. RESULTS: The serum and BALF levels of IL-18 in patients with sarcoidosis were significantly higher (p < 0.05) than those in IPF subjects and control groups. The percentages of T, B and NK cells in blood and BALF did not differ among all groups, while the blood and BALF CD4/CD8 ratios in patients with sarcoidosis were significantly higher (p < 0.05) than those in the other groups. Among all subjects, the serum levels of IL-18 correlated positively with the CD4/CD8 ratios in BALF (r = 0.693, p < 0.001). CONCLUSIONS: As to the levels of IL-18 in serum and BALF, there were differences between sarcoidosis and IPF indicating a different role of IL-18 in the pathogenesis of these diseases. Measurement of circulating IL-18 might have a potential of clinical utility in the differential diagnosis of sarcoidosis versus IPF.
    [Abstract] [Full Text] [Related] [New Search]